2021

BIG and World Cancer Day – Together, all our actions matter

OlympiA adjuvant trial results show olaparib for BRCA 1/2 mutated and high-risk early breast cancer reduced recurrence risk by 42%

Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer

Breast International Group’s new Executive Board

First results of the European AURORA study: towards a better understanding of the molecular changes driving metastatic breast cancer

Metastatic breast cancer, an ultramarathon

First results of MA.32 trial: Common diabetes drug not effective against early-stage breast cancer, landmark trial reveals